Conference Reports for NATAP

AIDS 2022 July 29 - Aug 2 24th Intl AIDS Conference Back c

WHO LA-CAB PrEP Guidelines at IAS 2022       Download the PDF here   • IAC: AVAC, BMGF, CIFF, MEDACCESS, UNITAID AND VIIV HEALTHCARE ANNOUNCE COLLABORATION TO CATALYSE MORE AFFORDABLE ACCESS TO LONG-ACTING CABOTEGRAVIR FOR HIV PREVENTION - (07/29/22)   • IAC: ViiV HEALTHCARE AND THE MEDICINES PATENT POOL SIGN NEW VOLUNTARY LICENSING AGREEMENT TO EXPAND ACCESS TO INNOVATIVE LONG-ACTING HIV PREVENTION MEDICINE - (07/29/22)   IAC: Long acting injectable cabotegravir: updated efficacy and safety results from HPTN 084 - (07/30/22)   IAC: Real-World Utilization of HIV Pre-Exposure Prophylaxis (PrEP) by Cisgender and Transgender Individuals in the United States - (08/01/22)   Guidelines on long-acting injectable cabotegravir for HIV prevention